A Anagliptin DMF (Drug Master File) is a document detailing the whole manufacturing process of Anagliptin active pharmaceutical ingredient (API) in detail. Different forms of Anagliptin DMFs exist exist since differing nations have different regulations, such as Anagliptin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Anagliptin DMF submitted to regulatory agencies in the US is known as a USDMF. Anagliptin USDMF includes data on Anagliptin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Anagliptin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Anagliptin suppliers with USDMF on PharmaCompass.